Loading clinical trials...
Loading clinical trials...
See Detailed Description
Conditions
Interventions
abacavir/lamivudine
abacavir
+2 more
Locations
76
United States
GSK Investigational Site
Los Angeles, California, United States
GSK Investigational Site
Oakland, California, United States
GSK Investigational Site
Fort Lauderdale, Florida, United States
GSK Investigational Site
Fort Lauderdale, Florida, United States
GSK Investigational Site
Fort Lauderdale, Florida, United States
GSK Investigational Site
Fort Myers, Florida, United States
Start Date
July 16, 2002
Primary Completion Date
May 25, 2004
Completion Date
May 25, 2004
Last Updated
March 24, 2020
NCT06857071
NCT06627764
NCT06900829
NCT06694805
NCT04142047
NCT05398185
Lead Sponsor
ViiV Healthcare
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions